The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bristow Michael R since 2006.
The trader's CIK number is 1266125.
At the time of the last reporting, Bristow Michael R was the Chief Science & Medi of Arca Biopharma, Inc.. (stock ticker symbol ABIO).
Also see all insider trading activities at Arca Biopharma, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2006 | MYOG | 0 | $0 | 116,149 | $3,917,675 | 69,540 | $86,924 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | ABIO | 0 | $0 | 1,483 | $3,726 | 0 | $0 |
2016 | ABIO | 0 | $0 | 2,696 | $8,247 | 0 | $0 |
2015 | ABIO | 0 | $0 | 1,809 | $11,450 | 0 | $0 |
2014 | ABIO | 0 | $0 | 13,853 | $18,008 | 0 | $0 |
2013 | ABIO | 1,069,290 | $500,427 | 0 | $0 | 0 | $0 |
2009 | ABIO | 0 | $0 | 0 | $0 | 7,394 | $443 |
2. Arca Biopharma, Inc. (ABIO)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2006-09-05 | MYOG | Option Ex | 9,602 | 1.25 | 12,002 |
2006-09-05 | MYOG | Sale | 29,602 | 35.00 | 1,036,070 |
2006-09-01 | MYOG | Option Ex | 44,938 | 1.25 | 56,172 |
2006-09-01 | MYOG | Sale | 56,547 | 35.00 | 1,979,145 |
2006-01-03 | MYOG | Option Ex | 15,000 | 1.25 | 18,750 |
2006-01-03 | MYOG | Sale | 30,000 | 30.08 | 902,460 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-04-04 | ABIO | Sale | 720 | 2.41 | 1,735 |
2017-02-28 | ABIO | Sale | 763 | 2.61 | 1,991 |
2016-09-20 | ABIO | Sale | 1,972 | 2.89 | 5,699 |
2016-04-05 | ABIO | Sale | 724 | 3.52 | 2,548 |
2015-09-18 | ABIO | Sale | 1,809 | 6.33 | 11,450 |
2014-09-18 | ABIO | Sale | 13,853 | 1.30 | 18,008 |
2013-01-25 | ABIO | Buy | 1,069,290 | .47 | 500,427 |
2009-10-14 | ABIO | Option Ex | 7,394 | .06 | 443 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bristow Michael R (Chief Science & Medi of Arca Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.